Pintér D - Search Results

1

The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson's Disease.

Pintér D, Juhász A, Harmat M, Janszky J, Kovács N. Pintér D, et al. Sci Rep. 2020 Jun 22;10(1):10050. doi: 10.1038/s41598-020-66692-5. Sci Rep. 2020. PMID: 32572075 Free PMC article.

2

Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale.

Makkos A, Kovács M, Pintér D, Janszky J, Kovács N. Makkos A, et al. Among authors: pinter d. Parkinsonism Relat Disord. 2019 Jan;58:79-82. doi: 10.1016/j.parkreldis.2018.08.018. Epub 2018 Aug 26. Parkinsonism Relat Disord. 2019. PMID: 30174275

3

Trimetazidine and parkinsonism: A prospective study.

Pintér D, Kovács M, Harmat M, Juhász A, Janszky J, Kovács N. Pintér D, et al. Parkinsonism Relat Disord. 2019 May;62:117-121. doi: 10.1016/j.parkreldis.2019.01.005. Epub 2019 Jan 4. Parkinsonism Relat Disord. 2019. PMID: 30638818

4

[Selection of the optimal device-aided therapy in Parkinson's disease].

Kovács N, Aschermann Z, Juhász A, Harmat M, Pintér D, Janszky J. Kovács N, et al. Among authors: pinter d. Ideggyogy Sz. 2019 Jan 30;72(1-2):5-11. doi: 10.18071/isz.72.0005. Ideggyogy Sz. 2019. PMID: 30785241 Free article. Review. Hungarian.

5

Screening for Problematic Internet Use May Help Identify Impulse Control Disorders in Parkinson's Disease.

Kovács M, Makkos A, Pintér D, Juhász A, Darnai G, Karádi K, Janszky J, Kovács N. Kovács M, et al. Among authors: pinter d. Behav Neurol. 2019 Feb 3;2019:4925015. doi: 10.1155/2019/4925015. eCollection 2019. Behav Neurol. 2019. PMID: 30863462 Free PMC article.

6

Minimal clinically important difference for the quality of life in essential tremor questionnaire.

Pintér D, Makkos A, Kovács M, Janszky J, Kovács N. Pintér D, et al. Mov Disord. 2019 May;34(5):759-760. doi: 10.1002/mds.27660. Epub 2019 Apr 2. Mov Disord. 2019. PMID: 30938851 No abstract available.

7

Long-term successful treatment of chronic inflammatory demyelinating polyneuropathy-like polyneuropathy induced by levodopa-carbidopa intestinal gel with intravenous immunoglobulin.

Pintér D, Deli G, Juhász A, Pál E, Janszky J, Kovács N. Pintér D, et al. Eur J Neurol. 2019 Dec;26(12):e96-e97. doi: 10.1111/ene.14047. Epub 2019 Aug 9. Eur J Neurol. 2019. PMID: 31330074 No abstract available.

8

The Parkinson's Disease Composite Scale Is Adequately Responsive to Acute Levodopa Challenge.

Pintér D, Martinez-Martin P, Janszky J, Kovács N. Pintér D, et al. Parkinsons Dis. 2019 Sep 10;2019:1412984. doi: 10.1155/2019/1412984. eCollection 2019. Parkinsons Dis. 2019. PMID: 31583072 Free PMC article.

9

Which Scale Best Detects Treatment Response of Tremor in Parkinsonism?

Pintér D, Forjaz MJ, Martinez-Martin P, Rodriguez-Blazquez C, Ayala A, Juhász A, Harmat M, Janszky J, Kovács N. Pintér D, et al. J Parkinsons Dis. 2020;10(1):275-282. doi: 10.3233/JPD-191800. J Parkinsons Dis. 2020. PMID: 31868685

10

Comment on "Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic study".

Pintér D, Janszky J, Kovács N. Pintér D, et al. Mov Disord. 2020 Feb;35(2):375. doi: 10.1002/mds.27948. Mov Disord. 2020. PMID: 32056309 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters